Valiant Laboratories P/E Ratio
Valiant Laboratories P/E ratio. Valiant Laboratories (VALIANTLAB) P/E ratio is not applicable — EPS (TTM) ₹-0.51. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Current EPS: ₹-0.51
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | 0.32 | 2 | Profit |
| Jun 2026 | 3.89 | 21 | Profit |
| Sept 2025 | 0.04 | 0 | Profit |
| Mar 2025 | 0.16 | 1 | Profit |
| Jun 2025 | 0.42 | 2 | Profit |
| Dec 2025 | -1.30 | -7 | Loss |
| Sept 2024 | -1.09 | -5 | Loss |
| Mar 2024 | -0.33 | -1 | Loss |
Healthcare Peers with Valid P/E Ratios — VALIANTLAB Comparison
Healthcare sector average P/E 56.26, median 32.41 — VALIANTLAB excluded (negative EPS).
Sector Average PE
56.26
Sector Median PE
32.41
Lowest PE
2.04
Profitable Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 3.98 | ₹6,206 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| GKB Ophthalmics | GKB | 5.88 | ₹32 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see Valiant Laboratories share price chart.
- Examine Valiant Laboratories quarterly financials for recent quarterly revenue, profit and EPS trends.
- Also explore VALIANTLAB stock price history to track price trends across different timeframes.